Bioharvest Sciences Inc (BHST) Stock Price, Quote & News

Company Profile

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and function...

Industry: Packaged Foods

Sector: Consumer Defensive

Phone: 604 689 5722

Fax: 604 685 9182

Website: www.bioharvest.com

Address:

1140-625 Howe Street, Vancouver, Canada

newsfile_corp May. 13 at 9:33 PM

https://nfne.ws/297382 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #Appointment #NASDAQ #Inve

0 · Reply

BioHarvest_Sciences May. 13 at 4:05 PM

$BHST News Release--> BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications. CDMO program now advances to Stage 2 of ongoing development agreement. Read Full Release: https://ir.bioharvest.com/news/default.aspx

0 · Reply

focafoca99 May. 13 at 12:19 PM

$BHST achieved a milestone as it completed Stage 1 of its saffron cell‑bank development, moving the program toward Stage 2.

0 · Reply

newsfile_corp May. 13 at 12:01 PM

https://nfne.ws/297297 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

BioHarvest_Sciences May. 12 at 2:13 PM

$BHST News Release--> BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using its Proprietary Botanical Synthesis Platform. View news release: https://ir.bioharvest.com/news/default.aspx The source plant is widely regarded as one of the most valuable fragrance raw materials in the world.

0 · Reply

newsfile_corp May. 12 at 11:31 AM

https://nfne.ws/297104 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

forgottenchuck May. 11 at 11:59 PM

$BHST $CELH

1 · Reply

forgottenchuck May. 11 at 11:57 PM

$BHST look for CELCIUS to buyout BIOHARVEST going forward. celcius wants the vinia hydration drinks from what im hearing and bioharvest dont have the capital to push the hydration drinks into the the next level. you heard it here frist

0 · Reply

forgottenchuck May. 11 at 7:55 PM

$BHST keep a eye on the vinia hydration drinks. they need to get this in retail stores nation wide. thats where ILAN has fook up bigtime and has been replaced

0 · Reply

sepsis74 May. 11 at 2:29 PM

$BHST someone really doesn't like the new CEO. Volume has been 4-5x normal over the past 2 days.

0 · Reply

BioHarvest Sciences Appoints New Head of Business Development for its CDMO Division

May 13, 2026, 8:00 AM EDT - 11 hours ago

BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications

May 12, 2026, 7:30 AM EDT - 1 day ago

BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform

Apr 30, 2026, 4:05 PM EDT - 13 days ago

BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026

Apr 29, 2026, 8:30 AM EDT - 14 days ago

BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy

Mar 31, 2026, 4:30 PM EDT - 6 weeks ago

BioHarvest Sciences Earnings Call Transcript: Q4 2025

Mar 31, 2026, 4:02 PM EDT - 6 weeks ago

BioHarvest Sciences Reports Fourth Quarter and Full-Year 2025 Financial Results

Mar 31, 2026, 8:00 AM EDT - 6 weeks ago

BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform

Mar 26, 2026, 7:30 AM EDT - 6 weeks ago

BioHarvest Sciences Announces that VINIA is Now the No.1 Resveratrol Polyphenol Brand in the United States

Mar 17, 2026, 8:30 AM EDT - 2 months ago

BioHarvest Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026

Mar 13, 2026, 4:53 PM EDT - 2 months ago

BioHarvest Sciences Announces Grant of Long-Term Incentive Awards to Employees, Officers and Directors

Mar 5, 2026, 7:30 AM EST - 2 months ago

BioHarvest Sciences Announces Board Transition and Appointment of Prof. Hezi Levy

Mar 3, 2026, 8:30 AM EST - 2 months ago

BioHarvest Sciences to Participate in 38th Annual Roth Conference on March 22-24, 2026

2026-02-19T09:55:30.000Z - 2 months ago

BioHarvest Sciences initiated with a Buy at Roth Capital

Jan 7, 2026, 7:30 AM EST - 4 months ago

BioHarvest Sciences Issues Year End Shareholder Letter

Dec 18, 2025, 7:30 AM EST - 5 months ago

BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform

Dec 3, 2025, 7:30 AM EST - 5 months ago

BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product

Nov 13, 2025, 4:30 PM EST - 6 months ago

BioHarvest Sciences Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:05 PM EST - 6 months ago

BioHarvest Sciences Reports Third Quarter 2025 Financial Results

Nov 12, 2025, 8:42 AM EST - 6 months ago

BioHarvest Sciences to Attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025

Nov 10, 2025, 4:18 PM EST - 6 months ago

BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter's Option to Purchase Additional Shares

2025-11-07T12:56:34.000Z - 6 months ago

BioHarvest Sciences 2.485M share Spot Secondary priced at $7.00

Nov 7, 2025, 7:30 AM EST - 6 months ago

BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock

2025-11-06T22:01:29.000Z - 6 months ago

BioHarvest Sciences files common shares offering, no amount given

Nov 6, 2025, 4:37 PM EST - 6 months ago

BioHarvest Announces Proposed Public Offering of Common Stock

Nov 4, 2025, 7:30 AM EST - 6 months ago

BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time

Oct 30, 2025, 7:30 AM EDT - 6 months ago

BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis

Sep 22, 2025, 6:32 AM EDT - 8 months ago

BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction

Sep 10, 2025, 1:00 PM EDT - 8 months ago

BioHarvest Sciences Transcript: Status Update

2025-09-10T13:40:45.000Z - 8 months ago

BioHarvest Sciences Inc. – Common Stock trading resumes

2025-09-10T13:35:33.000Z - 8 months ago

BioHarvest Sciences Inc. – Common Stock trading halted, volatility trading pause

Sep 10, 2025, 7:00 AM EDT - 8 months ago

BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale

Sep 2, 2025, 8:30 AM EDT - 9 months ago

BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET

Aug 12, 2025, 11:00 AM EDT - 9 months ago

BioHarvest Sciences Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 11, 2025, 8:00 AM EDT - 9 months ago

BioHarvest Sciences Earnings Call Transcript: Q2 2025

Aug 11, 2025, 7:30 AM EDT - 9 months ago

BioHarvest Sciences Reports Second Quarter 2025 Financial Results

2025-08-06T15:30:16.000Z - 10 months ago

BioHarvest Sciences management to meet with Craig-Hallum

Aug 4, 2025, 8:30 AM EDT - 10 months ago

BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time

Jul 23, 2025, 8:30 AM EDT - 10 months ago

BioHarvest Sciences to Present at Canaccord Genuity 45th Annual Growth Conference on August 12-14, 2025

Jun 4, 2025, 7:00 AM EDT - 1 year ago

BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles

May 21, 2025, 8:30 AM EDT - 1 year ago

BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound

May 15, 2025, 4:30 PM EDT - 1 year ago

BioHarvest Sciences Earnings Call Transcript: Q1 2025

May 15, 2025, 4:05 PM EDT - 1 year ago

BioHarvest Sciences Reports First Quarter 2025 Financial Results

May 12, 2025, 8:30 AM EDT - 1 year ago

BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company

2025-05-07T15:40:53.000Z - 1 year ago

BioHarvest Sciences management to meet with Craig-Hallum

2025-05-05T12:31:25.000Z - 1 year ago

Craig-Hallum bullish on BioHarvest Sciences, initiates with a Buy

2025-05-05T11:41:22.000Z - 1 year ago

BioHarvest Sciences initiated with a Buy at Craig-Hallum

May 1, 2025, 8:30 AM EDT - 1 year ago

BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time

2025-04-25T20:25:52.000Z - 1 year ago

BioHarvest Sciences participates in a conference call with Maxim Group

Mar 31, 2025, 4:30 PM EDT - 1 year ago

BioHarvest Sciences Earnings Call Transcript: Q4 2024

Mar 31, 2025, 4:05 PM EDT - 1 year ago

BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 17, 2025, 8:30 AM EDT - 1 year ago

BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time

Mar 6, 2025, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025

Mar 4, 2025, 8:30 AM EST - 1 year ago

BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells

Feb 18, 2025, 8:30 AM EST - 1 year ago

BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD

Feb 12, 2025, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18

Jan 22, 2025, 8:30 AM EST - 1 year ago

BioHarvest Announces Appointment of Sharon Malka to Board of Directors

Jan 8, 2025, 8:41 AM EST - 1 year ago

BioHarvest Issues Shareholder Letter and Provides Corporate Update

Dec 11, 2024, 6:00 AM EST - 1 year ago

Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology

Nov 25, 2024, 4:30 PM EST - 1 year ago

BioHarvest Sciences Earnings Call Transcript: Q3 2024

Nov 25, 2024, 4:05 PM EST - 1 year ago

BioHarvest Sciences Reports Third Quarter 2024 Financial Results

Nov 25, 2024, 8:30 AM EST - 1 year ago

BioHarvest Launches VINIA SuperFood Functional Tea Line

Nov 21, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024

Nov 18, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time

Nov 12, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences Begins Trading on the Nasdaq Global Market

Nov 7, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market

Oct 23, 2024, 8:30 AM EDT - 1 year ago

BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results

Oct 16, 2024, 8:47 AM EDT - 1 year ago

BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024

newsfile_corp May. 13 at 9:33 PM

https://nfne.ws/297382 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #Appointment #NASDAQ #Inve

0 · Reply

BioHarvest_Sciences May. 13 at 4:05 PM

0 · Reply

focafoca99 May. 13 at 12:19 PM

$BHST achieved a milestone as it completed Stage 1 of its saffron cell‑bank development, moving the program toward Stage 2.

0 · Reply

newsfile_corp May. 13 at 12:01 PM

https://nfne.ws/297297 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

BioHarvest_Sciences May. 12 at 2:13 PM

0 · Reply

newsfile_corp May. 12 at 11:31 AM

https://nfne.ws/297104 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

forgottenchuck May. 11 at 11:59 PM

$BHST $CELH

1 · Reply

forgottenchuck May. 11 at 11:57 PM

0 · Reply

forgottenchuck May. 11 at 7:55 PM

$BHST keep a eye on the vinia hydration drinks. they need to get this in retail stores nation wide. thats where ILAN has fook up bigtime and has been replaced

0 · Reply

sepsis74 May. 11 at 2:29 PM

$BHST someone really doesn't like the new CEO. Volume has been 4-5x normal over the past 2 days.

0 · Reply

SuperGreenToday May. 6 at 7:18 PM

$BHST

0 · Reply

sepsis74 May. 4 at 3:03 PM

$BHST is the change in federal status of cannabis something that could help Bioharvest? https://www.poynter.org/fact-checking/2026/did-the-federal-government-legalize-marijuana/

0 · Reply

newsfile_corp Apr. 30 at 8:06 PM

https://nfne.ws/295263 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #Earnings #QuarterlyResult

0 · Reply

BioHarvest_Sciences Apr. 29 at 9:13 PM

$BHST News Release-->BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate “Two-Lens” Growth Strategy. Ilan Sobel appointed to Board of Directors. Read Full News Release: https://bit.ly/4cHK8xU

0 · Reply

freed50 Apr. 29 at 2:12 PM

$GGII why is a $BHST press release on $GGII page?

1 · Reply

newsfile_corp Apr. 29 at 12:30 PM

https://nfne.ws/294872 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

1 · Reply

forgottenchuck Apr. 15 at 5:48 PM

$BHST i put in a order for some more chews and apparently there all out of chews. the good news is people are buying them the bad news is the supply side is not holding up. bad bussiness practice not having the chews when you need them. they said hopefully in june they will have more in stock.

0 · Reply

sepsis74 Mar. 31 at 10:23 PM

$BHST So typical. Management apparently had a bigger, better idea that will require more investment and more delayed gratification. Did they actually say whether or not they will need to raise more money?

0 · Reply

BioHarvest_Sciences Mar. 31 at 9:50 PM

$BHST News Release --> BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform Read full release: https://ir.bioharvest.com/news/default.aspx

0 · Reply

newsfile_corp Mar. 31 at 8:03 PM

https://nfne.ws/290705 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #Earnings #QuarterlyResult

0 · Reply

newsfile_corp Mar. 31 at 12:00 PM

https://nfne.ws/290629 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

forgottenchuck Mar. 30 at 5:48 PM

$BHST earnings report out tommorrow, should be interesting

0 · Reply

Market Cap	72.38M
Revenue (ttm)	34.51M
Net Income (ttm)	-11.14M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-32.28%
Debt to Equity Ratio	0.10

Volume	32,800
Avg Vol	29,518
Day's Range	N/A - N/A
Shares Out	19.62M
Stochastic %K	30%
Beta	0.81
Analysts	Strong Sell
Price Target	$12.75